Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PAAD | rs1932067 | chr1:26322081 | A/G | 8.97E-8 | 178 | 15.57 | 14.57 | 3.17 | KM Plot |
PAAD | rs1943496 | chr11:68470306 | G/A | 9.47E-10 | 177 | 15.57 | 14.02 | 2.2 | KM Plot |
PAAD | rs1957999 | chr16:68735835 | G/A | 4.6E-5 | 177 | 16.15 | 14.18 | 5.97 | KM Plot |
PAAD | rs1962291 | chr5:127445373 | A/G | 0.000152 | 178 | 7.87 | 13.95 | 16.17 | KM Plot |
PAAD | rs1980265 | chr6:44928868 | C/A | 9.64E-5 | 178 | 16.22 | 16.12 | 11.98 | KM Plot |
PAAD | rs199523190 | chr11:50304508 | G/GT | 9.35E-6 | 173 | 15.27 | 16.1 | 0.4 | KM Plot |
PAAD | rs199676718 | chr11:125732622 | G/A | 0.000114 | 175 | 15.87 | 12.2 | 4.1 | KM Plot |
PAAD | rs199712807 | chr11:125574252 | A/C | 0.000115 | 176 | 16.08 | 14.37 | 5.03 | KM Plot |
PAAD | rs199888479 | chr17:27165182 | CTGAAGCAGGAGAACTGCT/C | 1.73E-5 | 174 | 15.48 | 16.03 | 3.67 | KM Plot |
PAAD | rs199985130 | chr2:70491399 | GT/G | 0 | 174 | 15.3 | 17.5 | 1.03 | KM Plot |
PAAD | rs200113237 | chr2:70503479 | T/TAGGC | 0 | 177 | 15.37 | 18.43 | 1.03 | KM Plot |
PAAD | rs200280589 | chr7:20691527 | ATTC/A | 1.9E-6 | 176 | 15.55 | 15.67 | 3.67 | KM Plot |
PAAD | rs200300213 | chr10:102948167 | GC/G | 1.56E-7 | 172 | 15.82 | 14.03 | 3.17 | KM Plot |
PAAD | rs200365936 | chr11:49732793 | T/A | 2.4E-5 | 174 | 15.4 | 15.67 | 0.4 | KM Plot |
PAAD | rs200475355 | chr7:102747175 | T/A | 6.7E-8 | 178 | 16.17 | 12.2 | 3.43 | KM Plot |